1-16 of 16
A Jacobs
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples

Jasneet Kaur Khalsa, Justin Cha, Filippo Utro, Aishath Naeem, Ishwarya Murali, Yanan Kuang, Kevin Vasquez, Liang Li, Svitlana Tyekucheva, Stacey M. Fernandes, Lauren Veronese, Romain Guieze, Binu Kandathilparambil Sasi, Zixu Wang, John-Hanson Machado, Harrison Bai, Maryam Alasfour, Kahn Rhrissorrakrai, Chaya Levovitz, Brian P. Danysh, Kara Slowik, Raquel A. Jacobs, Matthew S. Davids, Cloud P. Paweletz, Ignaty Leshchiner, Laxmi Parida, Gad Getz, Jennifer R. Brown
Journal: Blood
Blood (2023) 142 (5): 421–433.
https://doi.org/10.1182/blood.2022016600
Published: 2023
Includes: Supplemental data
Journal Articles

Phase II Study of Short Course CHOP-Rituximab Followed by 90-Y Ibritumomab Tiuxetan as First-Line Treatment for Follicular Lymphoma: An Update and Extension of Preliminary Findings on Predictors of Relapse.

Rachel C. Jankowitz, MD, Kenneth A. Foon, MD, The Minh Luong, M.Sc, Stephanie R. Land, PhD, Nicholas A. DeMonaco, MD, Steven H. Swerdlow, MD, Judith Joyce, MD, Jennifer Osborn, MD, Terry Evans, MD, Samuel A. Jacobs, MD
Journal: Blood
Blood (2008) 112 (11): 2001.
https://doi.org/10.1182/blood.V112.11.2001.2001
Published: 2008
Journal Articles

Correlation between Tumor Uptake on Indium-111 Ibritumomab Tiuxetan Imaging and Size on CT to Disease Response on FDG PET/CT Scans Obtained Pre- and Post-Yttrium-90 Ibritumomab Tiuxetan Therapy for Non-Hodgkin Lymphoma.

Jacob M. Alexnder, MD, Judith M. Joyce, MD, Barry M. McCook, MD, Norbert Avril, MD, Stephanie R. Land, PhD, Mirsada Begovic, MD, PhD, Samuel A. Jacobs, MD
Journal: Blood
Blood (2005) 106 (11): 4781.
https://doi.org/10.1182/blood.V106.11.4781.4781
Published: 2005
Journal Articles

Phase II Trial of Abbreviated CHOP-Rituximab Followed by 90 Y Ibritumomab Tiuxetan (Zevalin) and Rituximab in Patients with Previously-Untreated Follicular Non-Hodgkin Lymphoma (NHL).

Nicholas A. DeMonaco, MD, Michael Wu, MD, Jennifer Osborn, MD, Terry Evans, MD, Kenneth A. Foon, MD, Steven H. Swerdlow, MD, Jeffrey Kant, MD, PhD, Judith Joyce, MD, Stephanie R. Land, PhD, Samuel A. Jacobs, MD
Journal: Blood
Blood (2005) 106 (11): 2449.
https://doi.org/10.1182/blood.V106.11.2449.2449
Published: 2005
Journal Articles

Cellular Localization Pattern of Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) in a Patient with Low-Grade Non-Hodgkin’s Lymphoma (NHL).

Samuel A. Jacobs, MD, Anthony M. Harrison, MD, Steven H. Swerdlow, MD, Kenneth A. Foon, MD, Norbert Avril, MD, Nick Vidnovic, Kenneth S. McCarty, MD, PHD, Wayne Saville, MD
Journal: Blood
Blood (2004) 104 (11): 4569.
https://doi.org/10.1182/blood.V104.11.4569.4569
Published: 2004
Journal Articles

Evaluation of Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) in Patients with Non-Hodgkin’s Lymphoma (NHL) Having Previously Received Autologous Stem Cell Transplant (ASCT).

Samuel A. Jacobs, MD, Barry McCook, MD, Frank Torok, MD, Norbert Avril, MD, Nick Vidnovic, Judy Joyce, MD, Arturo Molina, MD
Journal: Blood
Blood (2004) 104 (11): 5238.
https://doi.org/10.1182/blood.V104.11.5238.5238
Published: 2004
Journal Articles

Large Scale Analysis of Foamy Virus Vector Integration Sites in Human CD34+ Cells.

Grant D. Trobridge, PhD, Daniel G. Miller, MD, PhD, Michael A. Jacobs, PhD, James M. Allen, PhD, Erik Olson, Hans-Peter Kiem, MD, Rajinder Kaul, PhD, David W. Russell, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 496.
https://doi.org/10.1182/blood.V104.11.496.496
Published: 2004
Journal Articles

Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies

A Janowska-Wieczorek, AR Belch, A Jacobs, D Bowen, RA Padua, E Paietta, ER Stanley
Journal: Blood
Blood (1991) 77 (8): 1796–1803.
https://doi.org/10.1182/blood.V77.8.1796.1796
Published: 1991
Journal Articles

13-cis-retinoic acid v placebo in myelodysplasia [letter]

A Jacobs, RE Clark
Journal: Blood
Blood (1988) 72 (4): 1439–1440.
https://doi.org/10.1182/blood.V72.4.1439.1439
Published: 1988
Journal Articles

The effect of isoferritins on granulopoiesis

G Sala, M Worwood, A Jacobs
Journal: Blood
Blood (1986) 67 (2): 436–443.
https://doi.org/10.1182/blood.V67.2.436.436
Published: 1986
Journal Articles

Acid isoferritin inhibitory activity [letter]

A Jacobs
Journal: Blood
Blood (1983) 62 (3): 702–703.
https://doi.org/10.1182/blood.V62.3.702.702
Published: 1983
Journal Articles

The clearance of 131I-human plasma ferritin in man

M Worwood, SJ Cragg, AM Williams, M Wagstaff, A Jacobs
Journal: Blood
Blood (1982) 60 (4): 827–833.
https://doi.org/10.1182/blood.V60.4.827.827
Published: 1982
Journal Articles

Low molecular weight intracellular iron transport compounds

A Jacobs
Journal: Blood
Blood (1977) 50 (3): 433–439.
https://doi.org/10.1182/blood.V50.3.433.433
Published: 1977
Journal Articles

The effect of chelating agents on iron mobilization in Chang cell cultures

GP White, A Jacobs, RW Grady, A Cerami
Journal: Blood
Blood (1976) 48 (6): 923–929.
https://doi.org/10.1182/blood.V48.6.923.923
Published: 1976
Journal Articles

Iron metabolism, sickle cell disease, and response to cyanate

CM Peterson, JH Graziano, A de Ciutiis, RW Grady, A Cerami, M Worwood, A Jacobs
Journal: Blood
Blood (1975) 46 (4): 583–590.
https://doi.org/10.1182/blood.V46.4.583.583
Published: 1975
Journal Articles

Family Study in Addisonian Pernicious Anemia

S. ARDEMAN, MA., B.M., I. CHANARIN, M.D., A. JACOBS, M.D., LORRAINE GRIFFITHS, M.B.
Journal: Blood
Blood (1966) 27 (5): 599–610.
https://doi.org/10.1182/blood.V27.5.599.599
Published: 1966